Shared on17 Jul 25Fair value Decreased 5.41%
Despite an improved revenue growth outlook for Kanadevia, a higher discount rate has outweighed these gains, resulting in a lowered consensus analyst price target from ¥1110 to ¥1050. What's in the News Board approved proposal to amend Articles of Incorporation, specifically abolishing the position of Counselors to enhance governance and transparency.
Shared on01 May 25
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on23 Apr 25
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on17 Apr 25
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on09 Apr 25
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on02 Apr 25Fair value Increased 2.27%
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on26 Mar 25
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on19 Mar 25
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on12 Mar 25Fair value Increased 3.37%
AnalystConsensusTarget has decreased revenue growth from 3.7% to 2.1% and increased discount rate from 6.3% to 7.5%.